Inventor · disambiguated record
Dong Han
Also filed as: HAN DONG · HAN DONG C · HAN DONG-CHO
21 granted patents·16 pending applications·123 citations·filing 2004–2023
94Inventor score
Files withKOREA RES INST OF BIOSCIENCE10CHENG DAI6KWON BYOUNG MOG5IRM LLC3KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY3
Top patents by PatentIndex Score
37 records- 0191US8754209B2Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredientSIM TAE BO·Filed 2009·Granted Jun 17, 2014·30 cites·8 claims
- 0289US8546396B2N-(hetero)aryl, 2-(hetero)aryl—substituted acetamides for use as Wnt signaling modulatorsCHENG DAI·Filed 2010·Granted Oct 1, 2013·14 cites·18 claims
- 0386US8507491B2Compounds and compositions as hedgehog pathway inhibitorsCHENG DAI·Filed 2009·Granted Aug 13, 2013·11 cites·18 claims
- 0485US7250432B2Pharmaceutical compositions of diaryl-isoxazole derivatives for the prevention and treatment of cancersKOREA RES INST OF BIOSCIENCE·Filed 2004·Granted Jul 31, 2007·19 cites·3 claims
- 0583US10251893B2N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as Wnt signaling modulatorsNOVARTIS AG·Filed 2017·Granted Apr 9, 2019·3 cites·12 claims
- 0683US8178563B2Compounds and compositions as hedgehog pathway modulatorsGAO WENQI·Filed 2007·Granted May 15, 2012·12 cites·12 claims
- 0782US9238646B2N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as WNT signaling modulatorsCHENG DAI·Filed 2013·Granted Jan 19, 2016·5 cites·7 claims
- 0882US9181235B2Substituted pyridines for modulating the WNT signaling pathwayCHENG DAI·Filed 2011·Granted Nov 10, 2015·10 cites·15 claims
- 0981US8716288B2Composition comprising benproperine derivatives as active ingredients for preventing and treating angiogenesis-related diseasesKWON BYOUNG MOG·Filed 2013·Granted May 6, 2014·7 cites·16 claims
- 1080US7928133B2Compounds and compositions as hedgehog signaling pathway modulatorsIRM LLC·Filed 2007·Granted Apr 19, 2011·5 cites·6 claims
- 1175US9216964B2Hedgehog pathway modulatorsCHENG DAI·Filed 2013·Granted Dec 22, 2015·3 cites·18 claims
- 1271US7799811B2Agent for prevention and treatment of cancer comprising oxadiazole urea compound obstructing activity of statKOREA RES INST OF BIOSCIENCE·Filed 2007·Granted Sep 21, 2010·1 cites·2 claims
- 1367US9486490B2Composition for preventing or treating cancer containing extracts of artocarpus altilis fruits, leaves, or stems, or fractions thereof as active ingredientsKOREA RES INST BIOSCIENCE & BIOTECHNOLOGY·Filed 2013·Granted Nov 8, 2016·0 cites·4 claims
- 1465US6949682B2Cinnamaldehyde derivatives inhibiting growth of tumor cell and regulating cell cycle, preparations and pharmaceutical compositions thereofKOREA RES INST OF BIOSCIENCE·Filed 2004·Granted Sep 27, 2005·3 cites·5 claims
- 1565US2025082620A1Novel cinnamamide derivatives and use thereofKOREA RES INST BIOSCIENCE & BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 1659US2009263521A1Composition for the treatment of cancers and inhibition of metastasis containing extracts or fractions of the magnolia obovataKOREA RES INST OF BIOSCIENCE·Filed 2008·Application pending·0 cites
- 1759US2009311354A1Composition comprising extracts or fractions of magnolia obovata thunb for treating and preventing inflammation diseaseKOREA RES INST OF BIOSCIENCE·Filed 2008·Application pending·0 cites
- 1859US2007037889A1Anticancer composition comprising obovatol or obovatalKOREA RES INST OF BIOSCIENCE·Filed 2006·Application pending·0 cites
- 1958US8367736B2Anticancer composition comprising obovatol or obovatalKOREA RES INST OF BIOSCIENCE·Filed 2008·Granted Feb 5, 2013·0 cites·2 claims
- 2054US8183405B2Obovatol derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for the prevention and treatment of cancer containing the same as an active ingredientKWON BYOUNG-MOG·Filed 2008·Granted May 22, 2012·0 cites·2 claims
- 2154US7939542B2Cinnamaldehyde derivatives having improved solubility in water, a method for preparing the same and a pharmaceutical composition comprising the sameKOREA RES INST OF BIOSCIENCE·Filed 2008·Granted May 10, 2011·0 cites·9 claims
- 2253US2006035968A1Composition for preventing cancer comprising 2'-benzoyl-oxycinnamaldehydeKOREA RES INST OF BIOSCIENCE·Filed 2004·Application pending·0 cites
- 2353US2010125103A1Composition for the treatment of diabetes and metabolic syndrome containing obovatol and its synthesized derivativesTG BIOTECH CO LTD·Filed 2009·Application pending·0 cites
- 2452US2005124637A1Compounds and compositions as inhibitors of receptor tyrosine kinase activityIRM LLC·Filed 2004·Application pending·0 cites
- 2551US11945779B2Inhibitors of cancer metastasis through inhibiting migration and invasion of cancer cellsVSpharmtech·Filed 2019·Granted Apr 2, 2024·0 cites·8 claims
- 2651US2016082014A1N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulatorsCHENG DAI·Filed 2015·Application pending·0 cites
- 2747US9580399B2Geranyl flavonoid derivative with improved water solubility, a method for preparing the same, and a method for treating cancer using the sameKOREA RES INST BIOSCIENCE & BIOTECHNOLOGY·Filed 2015·Granted Feb 28, 2017·0 cites·9 claims
- 2847US2010056494A1Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseasesIRM LLC·Filed 2008·Application pending·0 cites
- 2946US9950071B2Hybrid anticancer prodrug simultaneously producing cinnamaldehyde and quinone methide and method for preparing sameNAT UNIV CHONBUK IND COOP FOUND·Filed 2015·Granted Apr 24, 2018·0 cites·15 claims
- 3044US2007185215A1Pharmaceutical composition containing obovatol as an active ingredient for the prevention and treatment of neurodegenerative diseasesKWON BYOUNG-MOG·Filed 2006·Application pending·0 cites
- 3144US2011092491A1Compounds and Compositions as Inhibitors of Receptor Tyrosine Kinase ActivityNOVARTIS AG·Filed 2010·Application pending·0 cites
- 3243US2009318376A1High Throughput Screening Method of Binding Inhibitor Between caspase3 and XIAP and Binding Inhibitor Screened TherebyKOREA RES INST OF BIOSCIENCE·Filed 2006·Application pending·0 cites
- 3343US2012196849A1Compounds and compositions as hedgehog pathway modulatorsGAO WENQI·Filed 2012·Application pending·0 cites
- 3442US8865762B2Method for the treatment of bone diseases comprising colforsin daropateKWON BYOUNG MOG·Filed 2010·Granted Oct 21, 2014·0 cites·5 claims
- 3540US2009306039A1Compounds and compositions as itpkb inhibitorsPAN SHIFENG·Filed 2007·Application pending·0 cites
- 3639US2016095845A1Composition comprising (s)-(-)-benproperine for preventing or treating cancerKWON BYOUNG MOG·Filed 2015·Application pending·0 cites
- 3739US2014004196A1Polyamide-amine dendrimer or derivative thereof-math1 gene nano particle and use thereof in treatment of hearing lossYANG SHI-MING·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dong Han files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →